Literature DB >> 16143294

Gene expression profiling in INS-1 cells overexpressing thioredoxin-interacting protein.

Alexandra H Minn1, Cynthia A Pise-Masison, Michael Radonovich, John N Brady, Ping Wang, Christina Kendziorski, Anath Shalev.   

Abstract

Thioredoxin-interacting protein (TXNIP) is overexpressed in diabetes and has deleterious effects on pancreatic beta-cells and the cardiovascular system. TXNIP is a regulator of the cellular redox state, but has also been suggested to act as a transcriptional repressor. However, the genes and pathways regulated by TXNIP remain unknown. We therefore compared gene expression in INS-1 insulinoma beta-cells overexpressing TXNIP and control LacZ-overexpressing cells using the Affymetrix 230A rat chip. Analysis with the Bayes methodology revealed 98 differentially expressed genes, 90 of which were down-regulated, consistent with the predicted role of TXNIP as a repressor. Using the PathwayAssist software, we found that affected genes were involved in cell death/survival and insulin secretion, and confirmed these findings by real-time RT-PCR and by functional studies. Thus, aside from regulating the cellular redox, TXNIP does modulate overall gene transcription and thereby may further enhance beta-cell death and impair insulin secretion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16143294     DOI: 10.1016/j.bbrc.2005.08.161

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  28 in total

Review 1.  Physiological insights gained from gene expression analysis in obesity and diabetes.

Authors:  Mark P Keller; Alan D Attie
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

2.  FOXO1 competes with carbohydrate response element-binding protein (ChREBP) and inhibits thioredoxin-interacting protein (TXNIP) transcription in pancreatic beta cells.

Authors:  Carly Kibbe; Junqin Chen; Guanlan Xu; Gu Jing; Anath Shalev
Journal:  J Biol Chem       Date:  2013-06-26       Impact factor: 5.157

3.  Carbohydrate response element-binding protein (ChREBP) plays a pivotal role in beta cell glucotoxicity.

Authors:  N Poungvarin; J K Lee; V K Yechoor; M V Li; T Assavapokee; P Suksaranjit; J J Thepsongwajja; P K Saha; K Oka; L Chan
Journal:  Diabetologia       Date:  2012-03-03       Impact factor: 10.122

Review 4.  Thioredoxin in the cardiovascular system.

Authors:  Cameron J World; Hideyuki Yamawaki; Bradford C Berk
Journal:  J Mol Med (Berl)       Date:  2006-10-05       Impact factor: 4.599

Review 5.  Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance.

Authors:  Samuel Lee; Soo Min Kim; Richard T Lee
Journal:  Antioxid Redox Signal       Date:  2012-06-26       Impact factor: 8.401

6.  Cytokines Regulate β-Cell Thioredoxin-interacting Protein (TXNIP) via Distinct Mechanisms and Pathways.

Authors:  Kyunghee Hong; Guanlan Xu; Truman B Grayson; Anath Shalev
Journal:  J Biol Chem       Date:  2016-02-08       Impact factor: 5.157

7.  Nod-like receptor protein 3 (NLRP3) inflammasome activation and podocyte injury via thioredoxin-interacting protein (TXNIP) during hyperhomocysteinemia.

Authors:  Justine M Abais; Min Xia; Guangbi Li; Yang Chen; Sabena M Conley; Todd W B Gehr; Krishna M Boini; Pin-Lan Li
Journal:  J Biol Chem       Date:  2014-08-19       Impact factor: 5.157

Review 8.  Diabetes pathogenic mechanisms and potential new therapies based upon a novel target called TXNIP.

Authors:  Lance Thielen; Anath Shalev
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2018-04       Impact factor: 3.243

9.  Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein.

Authors:  Geetu Saxena; Junqin Chen; Anath Shalev
Journal:  J Biol Chem       Date:  2009-12-03       Impact factor: 5.157

10.  Thioredoxin-interacting protein: a critical link between glucose toxicity and beta-cell apoptosis.

Authors:  Junqin Chen; Geetu Saxena; Imran N Mungrue; Aldons J Lusis; Anath Shalev
Journal:  Diabetes       Date:  2008-01-02       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.